CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hayat Pharmaceutical Industries Comp PSC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hayat Pharmaceutical Industries Comp PSC
P.O. Box 1564
Phone: +962 64162607p:+962 64162607 AMMAN, 11118  Jordan Ticker: HPICHPIC

Business Summary
Hayat Pharmaceutical Industries Company PSC is a Jordan-based company engaged in the pharmaceutical sector. The Company specializes in the manufacture of different forms of human pharmaceuticals, veterinary medicines, medical plasters, medical gauze and medical braces, in addition to the production of skin care and beauty supplies and surgical suture. The Company’s manufacturing facility is spread over an approximately 8,000 square meter area on the outskirts of the capital city Amman. The Company’s production areas are divided into the following: Solid production area, which covers tablets, capsules, dry suspension, suppositories, syrups and solutions, cream and ointments, and Semi-solid and Liquid production area, which includes creams, ointments, gels and emulsions, suppositories line, syrups line and shampoo line. The Company’s products include Anti-microbials, Gynecological, Dermatological, Gastrointestinal, Antihypertensives and Vasoactive, Neurological, and Respiratory products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board and General Manager Maher M.Al Kurdi 54 8/1/2005 2/17/2002
Vice Chairman of the Board, representing Comsal for Trade & Investment Co Fouad C.Bijali 1/1/2012
Chief Financial Officer Yahya H.Abdul Rahman 4/30/2012 4/30/2012
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Hayat Pharmaceutical Industries Co Plc
HPIC

General Information
Number of Employees: 191 (As of 12/31/2013)
Outstanding Shares: 9,500,000 (As of 9/30/2024)
Stock Exchange: AFM
Fax Number: +962 64163016


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024